Intense Therapeutic Ultrasound for the Treatment of Chronic Plantar Fasciitis
ITU
1 other identifier
interventional
33
0 countries
N/A
Brief Summary
A clinical trial evaluating the effectiveness, safety and patient tolerance for the use of Intense Therapeutic Ultrasound (ITU) for chronic, Plantar Fasciitis musculoskeletal tissue pain reduction began in August 2016 and was completed in April 2017. The clinical setting: University Foot and Ankle Institute, Santa Monica, California, USA; Single-Blinded, pivotal study for chronic plantar fasciitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2016
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 4, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 10, 2017
CompletedFirst Submitted
Initial submission to the registry
August 14, 2017
CompletedFirst Posted
Study publicly available on registry
August 18, 2017
CompletedResults Posted
Study results publicly available
November 17, 2017
CompletedDecember 7, 2017
October 1, 2017
8 months
August 14, 2017
August 21, 2017
November 14, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Patient Reported Pain Via the Universal Visual Analog Scale: Pass Criteria = at Least 25% Pain Reduction
Patient Reported Pain Reduction meeting or exceeding 25% using the Universal Visual Analog Scale. The Universal Visual Analog Scale is a 10 Point pain scale, where 0 = No Pain, 1 = slight Pain and 10 = the patient's worst imaginable pain. Ratings of 2 to 9 describe pain increases of 10%/Rating. For this measure a reduction of 25% on the Universal Visual Analog Scale is considered meeting the Pain Reduction Criteria. Lower Scale numbers compared to reported baseline ratings equates to pain reduction.
At 12 weeks after the first treatment
Secondary Outcomes (2)
Ultrasound Changes
At 12 Weeks after the first treatment
Percentage of Change of Pain and Hypoechoic Lesion Volume Compared to Baseline
At 12 Weeks after the first treatment
Study Arms (1)
Intense Therapeutic Ultrasound Treatment
EXPERIMENTALIntense Therapeutic Ultrasound treatment applied along the length and width of the proximal Plantar Fascia. 1000 - 5 Joule pulses were applied twice, four weeks apart.
Interventions
Eligibility Criteria
You may qualify if:
- Chronic Pain (\>90 days) from previously diagnosed Plantar Fasciitis, where "Standard of Care" regimens failed to relief pain in the affected anatomy.
- No History of surgery to the affected anatomy.
- No alternative treatment procedures within the last 90 days.
- Age: 18 - 85, depending on the study.
- Unilateral Pain
- Willingness to complete treatment and post treatment regimen as described.
- Patients who have provided written and verbal informed consent.
You may not qualify if:
- Patients currently enrolled in any other non-conservative, device, or Investigational New Drug clinical trial, or who have participated in a clinical study involving the Plantar Fascia, thirty days prior to study initiation;
- Patients who have participated in any other clinical study involving an investigational product 30 days prior to enrollment that, in the opinion of the Principal Investigator, could affect the outcome of this study;
- Patients who have received previous treatment in the symptomatic limb (not including conservative treatment);
- At the Principal Investigator's discretion, any patient that should be excluded based on their current condition or medical history.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Foot and Ankle Foundationlead
- Guided Therapy Systemscollaborator
Related Publications (6)
White WM, Makin IR, Barthe PG, Slayton MH, Gliklich RE. Selective creation of thermal injury zones in the superficial musculoaponeurotic system using intense ultrasound therapy: a new target for noninvasive facial rejuvenation. Arch Facial Plast Surg. 2007 Jan-Feb;9(1):22-9. doi: 10.1001/archfaci.9.1.22.
PMID: 17224484BACKGROUNDAlam M, White LE, Martin N, Witherspoon J, Yoo S, West DP. Ultrasound tightening of facial and neck skin: a rater-blinded prospective cohort study. J Am Acad Dermatol. 2010 Feb;62(2):262-9. doi: 10.1016/j.jaad.2009.06.039.
PMID: 20115948BACKGROUNDGliklich RE, White WM, Slayton MH, Barthe PG, Makin IR. Clinical pilot study of intense ultrasound therapy to deep dermal facial skin and subcutaneous tissues. Arch Facial Plast Surg. 2007 Mar-Apr;9(2):88-95. doi: 10.1001/archfaci.9.2.88.
PMID: 17372061BACKGROUNDLaubach HJ, Makin IR, Barthe PG, Slayton MH, Manstein D. Intense focused ultrasound: evaluation of a new treatment modality for precise microcoagulation within the skin. Dermatol Surg. 2008 May;34(5):727-34. doi: 10.1111/j.1524-4725.2008.34196.x.
PMID: 18429926BACKGROUNDMolloy T, Wang Y, Murrell G. The roles of growth factors in tendon and ligament healing. Sports Med. 2003;33(5):381-94. doi: 10.2165/00007256-200333050-00004.
PMID: 12696985BACKGROUNDLandorf KB, Keenan AM, Herbert RD. Effectiveness of foot orthoses to treat plantar fasciitis: a randomized trial. Arch Intern Med. 2006 Jun 26;166(12):1305-10. doi: 10.1001/archinte.166.12.1305.
PMID: 16801514BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Bias was mitigated as much as possible within the protocol by way of the blinding throughout the layers of patients and personnel involved in the study.
Results Point of Contact
- Title
- Rich Amodei, RDMS
- Organization
- Guided Therapy Systems
Study Officials
- PRINCIPAL INVESTIGATOR
Bob Baravarian, DPM
University Foot and Ankle Foundation
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 14, 2017
First Posted
August 18, 2017
Study Start
August 4, 2016
Primary Completion
April 10, 2017
Study Completion
April 10, 2017
Last Updated
December 7, 2017
Results First Posted
November 17, 2017
Record last verified: 2017-10
Data Sharing
- IPD Sharing
- Will not share